NeuroSpectrum Insights

Autism-focused medical device developer NeuroSpectrum Insights sets terms for $17 million IPO IPO Overview NeuroSpectrum Insights, which is developing a medical device for diagnosing neurological and neurodevelopmental disorders, announced terms for its IPO on Tuesday. The Bedminster, NJ-based company plans... Read more